John M. Sprague - Feb 20, 2023 Form 4 Insider Report for T2 Biosystems, Inc. (TTOO)

Role
Chief Financial Officer
Signature
/s/ John Sprague, Attorney-in-fact
Stock symbol
TTOO
Transactions as of
Feb 20, 2023
Transactions value $
-$1,682
Form type
4
Date filed
3/9/2023, 03:00 PM
Previous filing
Apr 11, 2022
Next filing
Feb 20, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TTOO Common Stock Options Exercise +4K +131.28% 7.05K Feb 20, 2023 Direct F1
transaction TTOO Common Stock Sale -$1K -1.55K -21.92% $0.65 5.5K Feb 22, 2023 Direct F2
transaction TTOO Common Stock Options Exercise +2.91K +52.96% 8.42K Feb 24, 2023 Direct F1
transaction TTOO Common Stock Sale -$677 -1.15K -13.64% $0.59 7.27K Feb 28, 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TTOO Restricted Stock Units Options Exercise $0 -4K -33.33% $0.00 8K Feb 20, 2023 Common Stock 4K Direct F1, F3
transaction TTOO Restricted Stock Units Options Exercise $0 -2.91K -50% $0.00 2.91K Feb 24, 2023 Common Stock 2.91K Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F2 The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person adopted by the reporting person on June 15, 2018.
F3 On February 20, 2022 the reporting person was granted 12,000 RSU's that vest in three equal annual installments commencing on February 20, 2023
F4 On February 24, 2021 the reporting person was granted 8,743 RSU's that vest in three equal annual installments commencing on February 24, 2022.